The effect of orlistat and ezetimibe, alone or in combination, on serum LDL and small dense LDL cholesterol levels in overweight and obese patients with hypercholesterolaemia

By Nakou E. S.   Filippatos T. D.   Georgoula M.   Kiortsis D. N.   Tselepis A. D.   Mikhailidis D. P.   Elisaf M. S.  

Current Medical Research and Opinion, Vol. 24, Iss. 7, 2008-07 ,pp. : 1919-1929

Informa Healthcare

Access to resources Recommend Favorite

The ORLIstat and CArdiovascular risk profile in patients with metabolic syndrome and type 2 DIAbetes (ORLICARDIA) study

By Didangelos T.P.   Thanopoulou A.K.   Bousboulas S.H.   Sambanis C.L.   Athyros V.G.   Spanou E.A.   Dimitriou K.C.   Pappas S.I.   Karamanos B.G.   Karamitsos D.T.  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1393-1401

Informa Healthcare

Access to resources Recommend Favorite

Elevated visfatin levels in overweight and obese children and adolescents with metabolic syndrome

By Kolsgaard Magnhild L.   Wangensteen Teresia   Brunborg Cathrine   Joner Geir   Holven Kirsten B.   Halvorsen Bente   Aukrust Pål   Tonstad Serena  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 69, Iss. 8, 2009-12 ,pp. : 858-864

Informa Healthcare

Access to resources Recommend Favorite

Effect of orlistat on glycaemic control in overweight and obese patients with type 2 diabetes mellitus: a systematic review and meta‐analysis of randomized controlled trials

By  

OBESITY REVIEWS, Vol. 16, Iss. 12, 2015-12 ,pp. : 1071-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite

Metabolic and Psychological Response to 7-Day Fasting in Obese Patients with and without Metabolic Syndrome

By  

Forschende Komplementärmedizin / Research in Complementary Medicine, Vol. 20, Iss. 6, 2013-06 ,pp. : 413-420

Karger

Access to resources Recommend Favorite